These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24963213)

  • 21. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
    Dolinšek J; Rižnik P; Sabath L; Mičetić-Turk D
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):253-9. PubMed ID: 26659704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fecal calprotectin as a biomarker effectiveness of various interventions in patients with inflammatory bowel disease].
    Lazebnik LB; Guseĭn-Zade MG; Efremov LI; Sagynbaeva VÉ; Kniazev OV
    Eksp Klin Gastroenterol; 2013; (8):11-6. PubMed ID: 24933942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel disease - glycomics perspective.
    Hanić M; Trbojević-Akmačić I; Lauc G
    Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1595-1601. PubMed ID: 31276732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls.
    Bosch S; Struys EA; van Gaal N; Bakkali A; Jansen EW; Diederen K; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):773-778. PubMed ID: 29112087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial.
    Scaioli E; Belluzzi A; Ricciardiello L; Del Rio D; Rotondo E; Mena P; Derlindati E; Danesi F
    Trials; 2019 Jun; 20(1):327. PubMed ID: 31171016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC; Heilmann RM; García-Sancho M; Sainz A; Ackermann MR; Suchodolski JS; Steiner JM; Jergens AE
    J Vet Intern Med; 2018 May; 32(3):999-1008. PubMed ID: 29624721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.
    Kostakis ID; Cholidou KG; Vaiopoulos AG; Vlachos IS; Perrea D; Vaos G
    Dig Dis Sci; 2013 Feb; 58(2):309-19. PubMed ID: 22899243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal markers in the management of inflammatory bowel disease.
    Dai C; Jiang M; Sun MJ
    Postgrad Med; 2018 Sep; 130(7):597-606. PubMed ID: 30063872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.